Tag: Business

Dr. Batra’s® brings the World’s first 5th Generation AI Skin analyser to India

New Delhi (India), May 31: Dr. Batra’s ® Healthcare; the largest chain of homeopathic clinics in the world, brings for the first time in India the World’s first AI-powered device, AI Skin Pro for diagnosis in the treatment of skin diseases. Imported from South Korea, the machine is the world’s 5th generation AI-powered skin analyzer.  It detects skin problems deep within the skin before they manifest themselves on the surface. It is a futuristic method of treating skin problems. Dr. Batra’s® has combined a very unique proposition in conjunction with Homoeopathy which is holistic, safe and without side-effects. Based on AI analysis, personalised treatments have been curated such as, AI Homeo Clear for Acne, AI Homeo Bright for Pigmentation disorders, AI Homeo Youth for anti-aging and AI HomeoReneu for multipurpose treatments.

Commenting on this new technology in India, Padmashri, Dr. Mukesh Batra, Founder and Chairman of Dr. Batra’s® Group of Companies, said, “Dr. Batra’s® has always been in the forefront of technology.   We are very excited to bring forth this new advanced AI technology, AI Skin Pro,for the first time in India to benefit patients of skin problems. A combination of the world’s latest technology with the 250 year old science of homeopathy will ensure better results for patients”.

The AI Skin Pro treatment option will be available in select Dr. Batra’s® clinics in all the metros and in select cities across India and Dubai.

About Dr. Batra’s®

With over 200+ clinics in around 160 cities across five countries, including India, Bangladesh, the UK, UAE, and Bahrain, Dr. Batra’s Homeopathy Clinics has over 300 doctors, including skin specialists, hair specialists and experienced homeopathic doctors. Dr. Batra’s ® has treated over 1 million patients and has been recognized as an ‘Icon of Indigenous Excellence in Healthcare’ by The Economic Times. Dr Batra’s ® specializes in Hair, Skin, Allergies, Child and Women’s Health, Mental Health, Sexual Health and Weight Management ailments, including Hair loss, Vitiligo, Psoriasis, Acne, Low immunity, Tonsillitis, Stress Management, Migraine, Thyroid, PCOS, Menopause, Allergies, Sexual Health, Weight Management, Infertility and Male Infertility.

For more information:

Website: www.drbatras.com

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Mumbai (Maharashtra) [India], May 31: The Financial Times published it’s Customized Executive Education World Ranking of Bespoke Continuing Education Courses on May 22, 2023. After entering the ranking in 2022 for the first time in its history, Excelia Business School has moved up 8 places and now features in the TOP 50 worldwide. This rise acknowledges both the development and the quality of the continuing education courses offered by the school.

Among the top 10 French schools of the 75 business schools included in this ranking, Excelia Business School features in 10th place among the French institutions listed.

The unique feature of this ranking is that the responses given by corporate clients are of paramount importance, accounting for 80% of the score.

This year, Excelia Business School has risen in all the different criteria used to assess its training courses, particularly in terms of the “follow-up’ offered post-training (35th place worldwide).

Customized programmes for the Indian market Excelia organizes custom-made programs for various companies in Europe and is looking forward to developing more modules for the Indian market. The school is known for its expertise in various topics, such as adapting the tourism and hospitality industries to the new traveller’s behaviours, supporting the ecological transition of corporate organisations, as well as designing impactful CSR policies across sectors.

“By entering the Top 50 of the world’s best training courses and consolidating their position as the 10th French school, Excelia’s continuing education courses have once again made a name for themselves in the prestigious Financial Times world ranking. This achievement highlights the relevance of Excelia’s range of training courses in supporting the major societal changes that all sectors and companies are currently experiencing. The range of courses has been tailored as closely as possible to the needs of companies and the core skills required for their development, enabling Excelia to achieve the highest national and international standards.” says Bruno Neil, CEO, Excelia

About Excelia 

Created in 1988, Excelia is one of the leading French higher education groups. With a strong presence in its local regions and an international outlook, it comprises 4 schools: Excelia Business School, Excelia Tourism School, Excelia Digital School, and Excelia Academy. It currently educates some 5,500 students and boasts an alumni network of 42,000 members. It holds the following labels and accreditations: EESPIG, AACSB, EQUIS, AMBA and EFMD, as well as UNWTO. TedQual (United Nations) in the field of tourism.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

New Delhi (India), May 31: Managing the fortunes of the wealthy, especially the crème de la crème, has become increasingly hard in recent years, considering the market volatility, newly emerging asset classes, and instability in the world’s financial markets, thanks to the pandemic. To deal with such a challenge and make the life of investors and money managers easy, a one of a kind portfolio management system— something that has not been launched till now for the Indian markets—is the need of the hour.

It would be truly ground-breaking, and that is what FINALYCA, India’s first all-in-one investment analytics platform offers.

How much easier would life be for global, domestic asset managers, family offices and wealth professionals. if there was a comprehensive bespoke solution powered by artificial intelligence (AI) and machine learning (ML) that can serve as a reliable performance analytics tool for investments?

Now, what if there was a unified platform that even research agencies, independent HNI investors, media platforms, business schools and other institutions could take advantage of to make accurate, data-driven, and efficient financial decisions?

FINALYCA makes all of this— and more— possible. Here’s how.

11 Features rolled in one, powerful platform

1. Unified platform for seamless investment management

In an instant, you can access data from multiple Mutual Fund houses, Alternative Investment Funds, Portfolio Management Services, and Unit Linked Insurance Policies providers—all in a single dashboard. At your fingertips, you have access to the nation’s leading databases, with over 25 Trillion INR worth of assets parked across various PMSs, AIFs, MFs, and ULIP providers offering well over 2500 products.

2. 2500 + Available financial products

The data at your disposal includes asset flows, fund manager information, financial returns, fees, expenses, benchmarks for performance, and possible risks of all available products that provide investors with tons of transparency.

With the AIFs, mutual funds, PMSs, and ULIPs available, wealth managers can build diversified portfolios that align with the investment objectives and risk tolerance of clients.

3. Product cross-comparison like never before

You can compare different asset classes on the FINALYCA platform to come up with different investment strategies and highly optimized decisions that work best for you or your clients or readers if you are a media platform.

With the revolutionary Cross Comparison feature powered by proprietary algorithms, users, including foreign institutions, can analyse the performance of different ULIPS, MFs, AIFs, and PMSs side by side—from anywhere in the world without hassles.

4. Uniform analytical data

To guarantee a high degree of comparability between alternative forms of investments, FINALYCA provides uniform analytics of all tracked products’ information, such as risk statistics, expenses, fees, and financial returns.

5. All the portfolio data that you need

For all mapped investment products, you can access over 2 million security-level data points. You can get both historical and latest information for delivering customized insights to clients and subscribers if you are a media platform.

6. Seamless performance attribution

FINALYCA offers a cutting-edge ‘Performance Attribution’ feature that lets users gauge what is driving the active returns in the chosen investment product. The feature is especially useful in getting an informed opinion of a fund manager’s success rate and financial decisions.

7.Make the platform your own

The platform lets you take control; you can choose the perfect investment product independently by leveraging the proprietary analytics, accurate and up-to-date market data & research, and tons of customizations made possible by the numerous filters as well.

It is worth mentioning that with these insights, wealth managers will have no trouble executing even huge transactions for clients. Moreover, using the platform, students in business schools can learn from these investment methods and the strategies of market leaders.

8.New products galore

Another striking feature of the FINALYCA platform is that the powerful decision engine lets you beat the crowd and access new, high-return investment products that are undervalued because they are away from the spotlight.

9.News and research that you can count on

Right on the home screen, you will be able to keep yourself and the clients updated with the latest market news and also incidents that impact the world of finance. The news feed will be in an easy-to-read format, with the occasional deep-dive article on the most pressing issues.

For users, such as Independent H1N1 investors, this feature is a godsend, as it allows them to perform their own unbiased research using granular-level data on debt, equity, and hybrid portfolios.

10. Cloud technology that has no downtime

The technology used by FINALYCA is secure and accessible throughout the year, come day or night, thanks to the fact that the platform is hosted on the cloud. Given its highly secure nature, users can trust it to make huge financial decisions without any worry.

11. Web and mobile access

The FINALYCA platform can be accessed securely both on the web and on mobile phones using an app. Users can easily control who has access to the platform and also allow restricted access to the required parties based on the situation.

FINALYCA allows users to aggregate every investment class/ asset possible, visualize and analyze portfolio data instantly, create customizable reports, and have an overall seamless experience with the platform, whether it is on the site or the mobile app. Consequently, users can perform reliable investment research, investment planning, and portfolio analysis with the latest data and get guaranteed results. For free demo session visit www.finalyca.com

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

New Delhi (India), May 30: Magazine publishers are struggling with the necessity to modify their business models in an era where digital media predominates in order to remain viable. The sustainability of magazine publishers depends on their capacity to investigate new revenue streams as traditional media spending declines and digital platforms assume a dominant role in the media landscape. Magazine publishers can access revenue sources like syndication, IP licencing, branded content, and more by using their unique content. And surprisingly, Indian publishers have adopted these cutting-edge economic models, while Western publishers are only now starting to experiment with them, demonstrating an incredible amount of adaptation.

Syndication: Expanding Reach and Revenue Potential

Syndication, a practice that involves licencing material to external platforms or publications, is one effective source of income for magazine publishers. Publishers may increase their audience and open up new revenue streams by syndicating their content. With this strategy, current material is repackaged for dissemination to other periodicals, websites, or even international markets. Publishers can demonstrate their knowledge and draw in new readers while generating income from licencing agreements by working with respected syndication firms or utilising digital platforms.

Indian Magazine Publishers: Pioneering the Shift

While Indian magazine publishers have previously shown extraordinary adaptability, publishers from other parts of the world are only now beginning to explore the possibility of syndication. By syndicating articles, features, and sometimes entire issues to foreign newspapers and digital platforms, Indian magazines have been taking advantage of their rich content. By capitalising on the demand for a range of viewpoints and distinctive insights from developing economies, they have been able to reach new audiences and make significant revenues out of it. However, the art of doing this has been mastered by only a handful of leading groups in India.

Licensing Intellectual Property (IP): Unlocking New Revenue Streams

In addition to syndication, intellectual property (IP) licencing is another way that magazine publishers can commercialise their content. This entails allowing others to make use of your brand, your material, or your characters in a variety of mediums, including events, digital series, movies, merchandise, and more. Publishers may reach a larger consumer base and boost their revenue potential by expanding their brand outside of the conventional print medium. The conversion of magazine articles into best-sellers, creating brand-led on-ground events, the manufacturing of branded items, and even the creation of television or OTT programmes or even motion pictures are instances of successful IP licencing.

Embracing Branded Content: Navigating the Landscape of Native Advertising

Branded content alliances are another obvious source of income for magazine publishers. In order to create targeted, interesting content in partnership with advertisers and seamlessly incorporate their brand messaging inside the editorial structure of the magazine. Publishers can provide companies with an engaging and authentic approach to connecting with their target audience by utilising their expertise in storytelling and in-depth understanding of their readership. Both parties gain from this mutually beneficial partnership since publishers make money and advertisers have access to a highly premium captive audience. This, however, is yet to reach its full potential in any market as such. In India, again, the magazine publishers have been terrific in adapting to it, and a big play waits in regional content. Western publishers who are more purists in nature are yet to unlock their true potential, as I have personally seen many of them staying away from ‘advertorialising’ their editorial streams, whether it’s text or video.

Conclusion:

Magazine publishers must proactively look for cutting-edge methods to commercialise their priceless content as the digital revolution transforms the media environment. In an increasingly digitally driven world, syndication, IP licencing, and branded content partnerships offer promising revenue streams that can support magazines. While Western publishers are starting to adopt these tactics, Indian magazine publishers have already shown their ability to adapt by putting these business models into practise. Magazine publishers can continue to provide high-quality content while securing a long-term future in the rapidly changing media landscape by embracing these new revenue strategies.

About the author: Sunil Wuthoo is a veteran of the Indian Media Industry, having spent more than 2 decades in leadership roles across the biggest media conglomerates in the country. In his career, including stints with The Times Group, Zee Media, The Walt Disney Company and ABP, he has effectively directed and monitored functions like Sales, Marketing, Product, Content and Business Process & Operations in order to meet corporate objectives on a consistent basis. Sunil finished his master’s in computer management from Pune University and, after that, completed several executive education programs across Leadership, Change Management & Decision Making from Indian School of Business. He is also a certified coach by Results Coaching Systems, Franklin Covey entity. He now lives in Ashburn, VA with his family and is currently the Vice President- Business Strategy for COM4 Global Inc.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd

FY23 Results Highlights:– (Standalone)

·         Net Profit Reports Y-o-Y growth of 5.11% to Rs. 72.90 crore;

·         Total Income reports Y-o-Y growth of 10.52% to Rs. 532.79 crore;

·         EBITDA reports Y-o-Y growth of 5.86% to Rs. 111.65 crore.

·         Company recommends 15% dividend, Rs. 1.5 per share for FY 23

Q4FY23 Results Highlights:– (Standalone)

·         Net Profit Reports Y-o-Y growth of 14.00% to Rs. 12.56 crore;

·         Total Income reports Y-o-Y growth of 11.47% to Rs. 116.41 crore;

·         EBITDA reports Y-o-Y growth of 6.26% to Rs. 20.54 crore.

 Ahmedabad (Gujarat) [India], May 30: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies, has achieved the milestone of Rs. 533 crore in Revenue & Rs. 100 crore Profit before tax for the first time in a financial year. The company has reported its Best-ever results in a financial year with highest – Revenue, EBITDA and Net Profit during FY 2023. The company has recommended a dividend of 15%, Rs. 1.50 per share on the face value of Rs. 10 per share for the FY 2022-23.

The company reported a net profit of Rs. 72.90 crore for FY23 as against net profit of Rs. 69.36 crore in the corresponding period last year, a growth of 5.11%. Total Income for FY23 was reported at Rs. 532.79 crore, higher by 10.52% over the previous fiscal’s same period total income of Rs. 482.08 crore. The company reported EBITDA of Rs. 111.65 crore in FY23, rise of 5.86% as compared to EBITDA of Rs. 105.47 crore in FY22. EPS for FY23 was reported at Rs. 36.40 per share.

Commenting on the results and performance, Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Limited, said, “Company has achieved the milestone of Rs. 500 crore revenue and Rs. 100 Crore in Profit in FY23 with a robust operational and financial performance along with healthy growth in revenue, margins and profitability. We expect the growth momentum to continue and expect to get a further boost in the coming years. The company has set a target of achieving Rs. 750 crores in revenue by FY26 while maintaining or improving its margins. With a robust performance, the company has recommended a dividend of Rs. 1.5 per share.”

Highlights: Q4FY23 Results 

For Q4 ended FY23, the company reported a net profit of Rs. 12.56 crore as against a net profit of Rs. 11.02 crore in the corresponding period last year, a growth of 14.00%. Total Income for the Q4FY23 was reported at Rs. 116.41 crores, higher by 11.47% over the previous fiscal’s same period income of Rs. 104.4 crores. The company reported EBITDA of Rs. 20.54 crore in Q4 FY23, a rise of 6.26% as compared to Rs. 19.33 crore in the corresponding period last year. EPS for Q4FY23 was at Rs. 6.27 per share.

“Company has reported its highest-ever Revenue, EBITDA and Net Profit reported on a yearly basis. The company is reporting excellent growth in the domestic and export business and expects to maintain healthy growth in the years to come. Strategic growth initiatives, product and geographical expansion, and operational efficiency are likely to contribute to growth going forward, said Mr. Patel.

Update on Cephalosporin Expansion – In September 2021, the company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products. The company has invested Rs. 30 crores in the cephalosporin plant – including acquisition and subsequent capacity expansion using an internal source of funds. The plant is expected to contribute sales of around Rs. 150 crore in the next 3 years. The company has received approval from WHO-GMP for Tablet Capsule, dry-powder Suspension products.

Over the last 5 years, the company has delivered a 17.35% CAGR in profits and higher single-digit growth in sales. The company has been successful in increasing its profit margins from around 9.88% in FY18 to over 14.88% in FY23. The liquidity position of the company is on a strong foundation, supported by healthy cash accruals, no-term debt, and healthy return ratios. Backed by improvement in the company’s financial risk profile, steady growth in scale & margins, and healthy profitability, rating agency ICRA has upgraded the company’s long-term and short-term bank facilities to A and A1, respectively. Over the last few years, promoter group have gradually increased their stake in the company. Foreign institutional investors holding as on March 2023 stand at 1.27%.

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, WHO-GMP and ISO-9001: 2015. The company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, anti-diabetic, and anti-malaria, among others. The company has filed 25-plus patent applications and has been awarded seven patents. The company has a strong presence in the domestic market nationally, with a dedicated field force of over 600 personnel who cater to more than 30,000 doctors and chemists across the country.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Mr. Narayan Saboo, Chairman & Managing Director, Bigbloc Construction Ltd

Business Highlights: –   ·         Commenced commercial production at its 5-lakh cubic meter per annum AAC Blocks plant at Wada in Palghar, Maharashtra ·         In joint venture with Thailand’s SCG Group, setting up a 3 lakh cubic meter per annum plant for ALC Panels and AAC Blocks at Kapadvanj near Ahmedabad, Gujarat and has acquired 60,000 sq mtr land for the project. The plant is expected to start commercial production in FY23-24. ·         Expects to generate 2.5 – 3 lakh units of carbon credits per annum post all expansions are completed. BigBloc is the only company in the AAC segment which generates carbon credit. ·         Post completion of all expansion, Bigbloc will be the largest manufacturer of AAC blocks in India, with the production capacity of 13.75 lakh cubic meter per annum

Surat (Gujarat) [India], May 29: BigBloc Construction Limited, one of India’s largest manufacturers of Aerated Autoclaved Concrete (AAC) Blocks, Bricks and Panels, has reported a consolidated net profit of Rs. 30.14 crore (PAT margin 15.0%) for the Financial year ended March 2023, growth of 87.4% Y-o-Y as compared to the net profit of Rs. 16.08 crore (PAT margin 9.2%) in FY22. Total income during FY23 was reported at Rs. 200.94 crore, rise of 14.3% Y-o-Y as compared to total income of Rs. 175.78crore in FY22. EBITDA for FY23 stood at Rs. 50.84 crore (EBITDA Margin 25.3%), rise of 83.5% as against EBITDA of Rs. 27.70 crore (EBITDA Margin 15.8%) in FY22. EPS for FY23 stood at Rs. 4.28 per share. The Company has recommended 20% dividend, Rs. 0.40 per share on the face value of Rs. 2 per share for the FY 2022-23.

The Company’s wholly owned subsidiary – Bigbloc Building Elements Pvt Ltd has recently commenced commercial production of 5-lakh cubic meter (cbm) per annum AAC Block plant at Wada in Palghar, Maharashtra to meet growing demand of AAC blocks in Western India. At full capacity, Wada plant is expected to generate revenues of Rs. 200 crore per year and will employ around 350-400 people at the plant.

Incorporated in 2015, BigBloc Construction Ltd is one of the largest and only listed company in the AAC Block Space with an installed capacity of 8.25 lakh cbm per annum. Green and non-toxic building construction material, AAC blocks are economical, lightweight, soundproof, fire resistance with superior build quality and saves energy, eco-friendly and economical too compared to traditional bricks. It is the only company in this segment that generates carbon credits from its operations.  

Consolidated Financial Highlights:

(Rs. in cr.)

Particulars	FY23	FY22	% Change
Total Income	200.94	175.78	14.3%
EBITDA	50.84	27.70	83.5%
EBITDA Margin (%)	25.3	15.8	954 bps
PAT	30.14	16.08	87.4%
PAT Margin (%)	15.0	9.2	585 bps
EPS (in Rs.)	4.28	2.27	88.5%

Commenting on the development, Mr. Narayan Saboo, Chairman of Bigbloc Construction Ltd, said, “We feel proud to inform all our stakeholders that the company is progressing well on its long-term growth roadmap. The Company has reported excellent numbers for FY23, with the highest Revenue, EBITDA and Net Profit reported on a yearly basis. The company is growing from strength to strength, delivering robust operational and financial performance and maintaining healthy growth in revenue, margins and profitability. Strategic growth initiatives, operational efficiency and commitment to launching environment-friendly and sustainable building products will contribute to healthy growth and maximise value for all stakeholders in the medium to long term. We expect the growth momentum to continue and expect to get a further boost in coming years.”

For Q4FY23, the company reported a consolidated net profit of Rs. 5.56 crore on a total income of Rs. 47.24 crore. EBITDA for Q4FY23 was reported at Rs. 11.30 crore.

In a joint venture with Thailand’s SCG Group, the company is setting up a 3 lakh cbm per annum plant for ALC Panels and AAC Blocks at Kapadvanj Ahmedabad (Gujarat) and has acquired 60,000 sq mtr land for the project. The plant is expected to start commercial production in FY23-24.

“Wada project is eligible for a 60% subsidy from the state government, and the company has invested Rs. 48 crore so far in Phase I. Post completion of all expansion, the company’s total capacities will increase to 13.75 lakh cbm per annum, making it the largest manufacturer of AAC block in the country. The Company will be in a better position to serve the growing demand for AAC blocks in Western India and strengthen its leadership position in the AAC block space in India. The Company expects to generate around 2.5 to 3 lakh units of carbon credit every year post-expansion,” said Mr. Mohit Saboo, Director & CFO, BigBloc Construction Ltd.

 BigBloc Construction Limited is India’s leading AAC block and related products manufacturing company. AAC blocks are a superior quality building material that provides an unparalleled blend of strength, lightweight, thermal insulation, soundproofing, unsurpassed fire resistance and highly proficient building capability. The company markets its products under the brand name ‘NXTBLOC‘. The Company’s client includes Lodha, Adani Realty, India Bulls Real Estate, Prestige, Piramal, Oberoi Realty, Shirke Group, Shapoorji Pallonji Group, Raheja, PSP Projects, Larsen & Toubro, and Sunteck, among others.

Further, with a commitment towards keeping the carbon footprints to the lowest possible, the company is installing solar rooftop projects at its Umargam and Kapadvanj manufacturing facilities. The Company is installing a 450 KW solar rooftop facility at each of the plants. The Company will be able to replace approximately 33% of its power requirement at both its plant with renewable green energy – solar power.  

Highlights for Q4FY23:-

• Capacity utilization for Q4FY23 was around 80.11%, and for the full year, FY23 was 83.44%.
• Sales for Q4FY23 were lower due to Holi and the non-availability of labour at construction sites.
• The Company has added major clients like Shapoorji Pallonji. The Company has also started supplying Reliance Industries Limited at its Jamnagar site.
• The Company has started marketing in new territories of Maharashtra and Gujarat and also bolstered its marketing team.

The Company has completed a banking tie-up for financing of its upcoming expansion in the JV company – Siam Cement Bigbloc Construction Technologies Private Limited.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Neel Shah, Founder, Mentopreneur

Mumbai (Maharashtra) [India], May 30: In the dynamic realm of start-ups, where dreams soar and innovation knows no limits, there exists a towering presence that illuminates the path to entrepreneurial triumph – Mentopreneur, a premier brand consultancy firm in India, dedicated to empowering founders and start-ups in their extraordinary journey towards success.

Mentopreneur is led by visionary marketing maverick Neel Shah, whose prolonged 11-year career and an impressive portfolio of 100 brands have altered the landscape of brand strategy.

Neel Shah, The ‘Chief Mentor’ at Mentopreneur, is well-acquainted with the realm of brand building. His entrepreneurial journey began at the tender age of 19, when he co-founded his experiential marketing company before he moved to JWT. In 2020, when the start-up ecosystem surged, he established Schbang Theta, the consumer-centricity and branding division of Schbang—an esteemed marketing agency led by industry veterans Harshil Karia, Sohil Karia, and Akshay Gurnani. With a wealth of knowledge gained from servicing huge corporations like Baskin Robbins, Godrej Group, Pidilite Industries and L’Oreal Group, Shah set out to revolutionise the development trajectory of smaller firms and start-ups.

With the launch of Mentopreneur, Shah has ushered in a new age of strategic brand consultancy. Mentopreneur provides complete branding strategies, thorough marketing counsel and accurate asset planning, with an unrelenting dedication to fostering start-ups and brands across all business verticals. This distinct strategy guarantees that each start-up gets customised services that match their individual demands as opposed to traditional advertising solutions.

“I believe start-ups are more than just business ventures; they are seeds of transformation and vehicles of change,” stated Neel Shah. “By acting as an invaluable extension of a brand’s team, Mentopreneur becomes the driving force behind their vision, infusing innovation, creativity, and a deep understanding of consumer behaviour into every strategic campaign.”

With Mentopreneur on their side, start-ups can leverage the power of professional insights, market research and performance marketing skills to create a route to unmatched success.

In the future years, as start-ups continue to transform sectors and revolutionise the way we live, Mentopreneur will stay at the vanguard, providing these visionary businesses with the tools, strategies and assistance they need to fly above the competition. Together, Mentopreneur and the start-ups it supports will rewrite the story of success and possibly craft the next generation of Nifty50 enterprises.

You can follow mentopreneur on instagram @mentopreneur for latest updates or check out their website www.mentopreneur.com

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

New Delhi (India), May 30: Brace yourselves for the groundbreaking news as Unified Capital and Investments, a distinguished force in the financial realm, takes a leap forward with the eagerly awaited grand opening of its spanking new office in Delhi. This daring manoeuvre brings the company’s unmatched expertise and top-notch services within arm’s reach of the vibrant and pulsating financial terrain of the National Capital Region (NCR).

With a headline that packs a punch and an atmosphere of exhilaration that lingers, Unified Capital and Investments pulls back the curtain on its shiny new office, signifying a monumental milestone in their extraordinary journey. The decision to establish a stronghold in Delhi NCR underscores the unwavering commitment of the company to cater to the multifaceted and ever-changing demands of clients in this buzzing financial hub.

The inaugural ceremony witnessed the presence of eminent captains of industry, distinguished guests, and the crème de la crème of the company’s top brass. The event showcased, in all its splendor, the unfaltering dedication of Unified Capital and Investments in offering unmatched financial solutions, investment strategies, and unrivalled client service. The ultra-modern office space stands as a testament to their vision of fostering an environment that breeds collaboration, innovation, and expansion.

Ms. Aarti Suri, the visionary VP Banking of Unified Capital and Investments, brims with enthusiasm about this expansion, proclaiming, “The inauguration of our Delhi office signifies the commencement of a new chapter in our remarkable journey. We are thrilled to establish a formidable presence in Delhi NCR, a region renowned for its resplendent economy and boundless potential. This audacious move aligns perfectly with our mission to lead the financial industry and deliver excellence in every facet of our operations.”

The foray into Delhi NCR will enable Unified Capital and Investments to cater to a more extensive clientele, encompassing individuals, corporations, and institutions yearning for comprehensive financial solutions tailor-made to their idiosyncratic requirements. Armed with a cadre of seasoned professionals and a treasure trove of expertise in investment management, asset allocation, and financial planning, the company is poised to make an indelible mark in the region.

The new office location in Delhi shall serve as the nucleus of Unified Capital and Investments’ operations, fostering tighter collaboration with clients, partners, and stakeholders. It shall also facilitate the recruitment of top-notch talent from the region, further bolstering the company’s capabilities and guaranteeing the delivery of exceptional services to clients.

As Unified Capital and Investments flings open its doors in Delhi NCR, it embarks upon a thrilling odyssey, leveraging its unwavering expertise, innovation, and commitment to redefine the financial landscape of the region. Armed with a daring vision and a solid foundation, the company stands tall, poised to create an enduring impact and cultivate fruitful partnerships with clients in Delhi and beyond.

About Unified Capital and Investments:

Unified Capital and Investments stands tall as an esteemed financial powerhouse, ceaselessly committed to delivering comprehensive financial solutions to individuals, corporations, and institutions. With an unwavering focus on innovation, unrivaled expertise, and unparalleled client service, the company strives to help clients achieve their financial goals and navigate the labyrinthine complexities of the ever-evolving financial landscape.

Contact:

Unified Capital and Investments

Email: connect@unifiedcapital.com

Phone: +91 7499999995

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Hyderabad (Telangana) [India], May 30: In an inspiring event that left students brimming with excitement, Mr. Mike, Founder and CEO of Rotomaker, launched the highly anticipated AVGCI (Animation, Visual Effects, Gaming and Comics) Multimedia Training Institute during a captivating studio tour. The event served as a platform to showcase AVGCI’s unique selling propositions, highlighting its pivotal role in shaping the future of the creative industry.

The studio tour, a testament to the visionary leadership of Mike, served as an immersive experience, offering students a glimpse into the world of cutting-edge visual graphics and cinematic excellence. Walking through the state-of-the-art facilities, participants witnessed firsthand the technology, expertise, and creative environment that define AVGCI. From advanced animation studios to top-of-the-line equipment, every corner of the institute exuded a vibrant energy that stimulated imagination and innovation.

‘’AVGCI’s curriculum bridges theory and practice, empowering students to shape the future of the creative industry.” stated Mike, while addressing the press. He explained how the institute recognizes the importance of hands-on experience, providing students with access to cutting-edge technology and industry-standard software. This immersive approach equips students with the necessary tools to excel in their respective fields, fostering their creative growth and professional development.

As a grand finale, a lucky draw was conducted, with 20 students receiving exclusive pre-launch goodies, adding an extra touch of delight to an already remarkable day. The prizes, carefully selected to excite and inspire, added an extra layer of delight to the occasion.

For more information about AVGCI, please visit https://avgci.com

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Gujarat (India), May 30: Veerhealth Care Ltd – engaged in the business of ayurvedic, herbal and personal care products has successfully turnaround its business operations in FY23. Company has reported net profit of Rs. 1.58 crore and revenue from operations of Rs 13.27 crore in FY23. Company also successfully completed preferential issue of Rs. 5.90 crore to fund its expansion plans.

For FY23, company reported revenues of Rs. 13.27 crore, 38% growth YOY as against revenue of Rs. 9.62 crore in FY22. Company reported net profit of Rs. 1.58 crore in FY23 as against loss of Rs. 9.6 lakh in FY22. EPS for FY23 was Rs. 1.52 per share.

In the month of March 2023, company completed preferential allotment of 30.65 lakh equity shares of Rs. 10 each at Rs. 19.25 per share including premium of Rs. 9.25 per share amounting Rs. 5.90 crore. The funds are being utilised for the expansion of company’s manufacturing facilities, new product launches and install new manufacturing lines.

During Q4FY23, revenues of the company reported 85% growth to Rs. 3.73 crore as against revenue of Rs. 2.01 crore in Q4FY22. Company posted net profit of Rs. 1.04 crore during Q4FY23 as against loss of Rs. 34.81 lakh in Q4FY22.

Highlights:-

• Company has a strong product portfolio of over 100 Herbal and Ayurvedic Products in Skincare, Bodycare, Haircare, Oralcare, Healthcare and Fragrance
• Company has successfully completed Rs. 5.9 crore preferential issue of 30.65 lakh shares at Rs 19.25 per share to fund its expansion plans
• Company’s brand ‘Ayuveer’ and e-commerce platform is getting strong traction in the domestic and export markets; Started exports to USA and South Africa
• Company’s client includes Dava India, Gracious Pharma, Babuline Pharma, Graciera Pharma etc

Company has successfully turnaround the business operations in FY23 and ready for the next phase of growth and quantum jump in the revenue and profits. Company is progressing well on its long-term growth roadmap and expect to completed its expansion plans very soon. Company’s ‘Ayuveer’ brand is getting good traction in the domestic and export markets and company is planning to launch many innovative product in time to come. Company expect the growth momentum to continue and expect to get further boost in coming years.

Company has a strong product portfolio of over 100 Herbal and Ayurvedic Products in Skincare, Bodycare, Haircare, Oralcare, Healthcare and Fragrance. Company’s brand ‘Ayuveer’ and its e-commerce platform is getting strong traction in the domestic and export markets; Started exports to USA and South Africa. Company’s client includes Dava India, Gracious Pharma, Babuline Pharma, Graciera Pharma etc

The Company produces Intensive research-based quality products with expert guidance and enormous experience of renowned Vaid of Mumbai, Dr. Vinod C. Mehta, an Ayurvedic practioner since 30 years and Dr. Rajiv Bhirud, an expert in formulations of cosmetic and personal care products. The company is well-equipped with state-of-the-art manufacturing facilities and skilled personnel to ensure optimum utilization of resources with the best quality product.

Company has a vision to become a leading provider of health care and personal care products by making available research-based quality products to meet the varied health needs of customers. 

Ayurveer – Story

Ayuveer has been created from the founder’s passion for authentic products. The team is committed to bring supreme quality of products to you and your family. Ayuveer is not only about a business, but it is an endeavour to make every home cruelty free. Company wish to inspire every brand to get their products to follow Make In India. Company has carefully curated every product to make sure that only the best reaches to its customers. Company aim to provide you with excellent customer service, hassle free purchases and timely deliveries.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.